MedPath

Chagas Disease Diagnostic - Inconclusive Serology

Not Applicable
Completed
Conditions
Parasitemia
Protozoan Infections
Registration Number
NCT00511589
Lead Sponsor
UPECLIN HC FM Botucatu Unesp
Brief Summary

T. cruzi infection affects approximately five million people in Brazil. The diagnosis of the chronic phase of infection is performed by indirect serological methods which, nevertheless, leave inconclusive results. One of the direct methods used for T. cruzi identification, blood culture in LIT (liver infusion tryptose) medium, presents low sensitivity in that phase of the disease. A negative result does not eliminate the possibility of infection, but a positive test has high absolute diagnostic value, which enables the indication of antiparasitic treatment. Molecular diagnosis (PCR) in this phase is promising and can be used as a confirmatory test, particularly when individuals present inconclusive results in conventional serological tests, such as ELISA, HAI and IFI. This study aimed at improving blood culture sensitivity in LIT medium by performing PCR in individuals with positive and inconclusive serology for chagasic infection.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • individuals with positive or inconclusive results in conventional serological tests: ELISA, HAI and IFI for Chagas disease
Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Univerdidade Estadual Paulista

🇧🇷

Botucatu, São Paulo, Brazil

© Copyright 2025. All Rights Reserved by MedPath